Metabolomics Predictors for Metabolic Disease Remission After Metabolic Syndrome Surgery.

Active, not recruitingOBSERVATIONAL

Enrollment

150

Participants

Timeline

Start Date

October 1, 2024

Primary Completion Date

October 1, 2026

Study Completion Date

October 1, 2027

Conditions

Metabolic Syndrome

Interventions

DIAGNOSTIC_TEST

hypertension

diagnosed with hypertension

DIAGNOSTIC_TEST

diabetes

diagnosed with diabetes

DIAGNOSTIC_TEST

fatty liver

diagnosed with fatty liver on CT

Trial Locations (1)

The First Affiliated Hospital of Chongqing Medical University, Chongqing

All Listed Sponsors

lead

First Affiliated Hospital of Chongqing Medical University

OTHER

NCT06645730 - Metabolomics Predictors for Metabolic Disease Remission After Metabolic Syndrome Surgery. | Biotech Hunter | Biotech Hunter